- Home
- ZNTL vs FEAM Comparison
ZNTL vs FEAM Comparison
Compare ZNTL & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- FEAM
- Stock Information
- Founded
- ZNTL 2014
- FEAM 2016
- Country
- ZNTL United States
- FEAM United States
- Employees
- ZNTL N/A
- FEAM N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- FEAM Major Chemicals
- Sector
- ZNTL Health Care
- FEAM Industrials
- Exchange
- ZNTL Nasdaq
- FEAM Nasdaq
- Market Cap
- ZNTL 105.8M
- FEAM 94.7M
- IPO Year
- ZNTL 2020
- FEAM N/A
- Fundamental
- Price
- ZNTL $1.42
- FEAM $3.99
- Analyst Decision
- ZNTL Buy
- FEAM Strong Buy
- Analyst Count
- ZNTL 6
- FEAM 2
- Target Price
- ZNTL $6.53
- FEAM $9.75
- AVG Volume (30 Days)
- ZNTL 729.8K
- FEAM 132.7K
- Earning Date
- ZNTL 11-11-2025
- FEAM 11-12-2025
- Dividend Yield
- ZNTL N/A
- FEAM N/A
- EPS Growth
- ZNTL N/A
- FEAM N/A
- EPS
- ZNTL N/A
- FEAM N/A
- Revenue
- ZNTL $26,865,000.00
- FEAM N/A
- Revenue This Year
- ZNTL N/A
- FEAM N/A
- Revenue Next Year
- ZNTL N/A
- FEAM N/A
- P/E Ratio
- ZNTL N/A
- FEAM N/A
- Revenue Growth
- ZNTL N/A
- FEAM N/A
- 52 Week Low
- ZNTL $1.01
- FEAM $2.82
- 52 Week High
- ZNTL $4.46
- FEAM $24.84
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- FEAM 52.42
- Support Level
- ZNTL $1.40
- FEAM $3.72
- Resistance Level
- ZNTL $2.02
- FEAM $4.50
- Average True Range (ATR)
- ZNTL 0.11
- FEAM 0.31
- MACD
- ZNTL -0.05
- FEAM 0.04
- Stochastic Oscillator
- ZNTL 4.76
- FEAM 57.50
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.